US 10526604
Modulation of nuclear-retained RNA
granted A61PA61P15/00A61P21/00
Quick answer
US patent 10526604 (Modulation of nuclear-retained RNA) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P15/00, A61P21/00, A61P21/04, A61P25/14